[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
INDICES> Re: Nimesulide and harm in pregnancy (2)
- From: DID <did.jms@imul.com>
- Date: Sat, 23 Dec 2000 10:11:34 -0500 (EST)
INDICES: Nimesulide and harm in pregnancy (2)
-------------------------------------------------------------------
Dear Indices users,
RE: NIMESULIDE AND HARM IN PREGNANCY:
NSAIDS should not be the first option painkillers for a pregnant mother.
Worse still, when a drug is relatively new, in a given country, and with
reports all over the place about its toxicity. Nimesulide has been
particularly implicated as a causer of dangerous hepatic disease. Why was
such a drug, quite a new member in a number of respects, seen as the resort
for a pregnant woman. If she picked it from a pharmacy or drug store on her
initiative, or if it was prescribed, then this clearly proves that people
should be taught on drugs and drug use, and that medicine possession should
be restricted to those relevantly trained or retrained to handle them.
Look at it this way, that all your programmes and ideas should
better the lives of ordinary citizens. Otherwise, new drugs, are always
adequately marketed to healthworkers and the general public, to induce use.
A large number of healthworkers and general public do not even suspect that
new chemicals are not necessarily superior to old alternatives, what matters
to many is that the higher the price the better. Of course packages must be
nice, but a correlation that the more nice looking a package is, then the
better the medicine is also common,and unknowingly stretched.
You could notice that physical harm was documented, in this particular
case. How sure are we that there was no biochemical harm, only
manifesting as reduced amount of amniotic fluid. How about long term
consequences? Who will ever document such in many developing countries?
Regards,
George Kibumba, MPS(Uganda).
Drug Information Pharmacist
Drug Information Desk,
Joint Medical Store,
P.O.BOX 4501, KAMPALA, Uganda(E.A)
e-mail: did.jms@imul.com
>Tel: 256-41-268482
>fax: 256-41-267298
--
Send mail for the `INDICES' conference to `indices@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-indices@usa.healthnet.org'.
|